HomeATOS • NASDAQ
add
Atossa Therapeutics Inc
Previous close
$0.64
Day range
$0.64 - $0.67
Year range
$0.55 - $1.81
Market cap
83.06M USD
Avg Volume
647.44K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.15M | -20.71% |
Net income | -6.35M | 18.15% |
Net profit margin | — | — |
Earnings per share | -0.05 | 16.67% |
EBITDA | -7.15M | 20.63% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 71.08M | -19.64% |
Total assets | 76.44M | -20.58% |
Total liabilities | 4.97M | -5.14% |
Total equity | 71.48M | — |
Shares outstanding | 129.17M | — |
Price to book | 1.16 | — |
Return on assets | -22.93% | — |
Return on capital | -24.63% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -6.35M | 18.15% |
Cash from operations | -7.05M | -26.57% |
Cash from investing | 0.00 | — |
Cash from financing | 3.37M | — |
Net change in cash | -3.68M | 33.91% |
Free cash flow | -5.55M | -60.64% |
About
Founded
2008
Headquarters
Website
Employees
15
